LUMA Vision secures FDA clearance for its VERAFEYE platform

Our portfolio company LUMA Vision has secured FDA clearance for its VERAFEYE platform.

VERAFEYE supports physicians throughout a cardiac procedure. It builds a live 2D and 3D map of the heart, its vessels and surrounding structures, giving cardiologists a continuous view of what is happening as they treat the patient.

The clearance is an important step towards the commercial launch of VERAFEYE in early 2027.

Click here for the full press release.